Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Dyspnea and Cardiotoxicity in Patients With Multiple Myeloma Who Receive Carfilzomib: A Prospective Pilot Study

NCT04827563 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04827563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04827563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Dyspnea and Cardiotoxicity in Patients With Multiple Myeloma Who Receive Carfilzomib: A Prospective Pilot Study
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Terminated
Start date
March 22, 2021
Completion date
September 8, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, dyspnea, multiple myeloma, shortness of breath